Research Tracker›Biomarker Atlas›Long COVID›Neurofilament light chain (NfL)

Neurofilament light chain (NfL) in Long COVID

Neurofilament light chain (NfL), also described as Axonal damage marker, is a neurological marker reported as elevated in Long COVID (PASC, Post-Acute Sequelae of COVID-19) when patients are compared with healthy controls. The cited literature links this alteration to neurological LC, brain fog. The finding is drawn from Lai et al. 2023; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedNeurologicalLOINC 94635-5

Summary

Direction in Long COVID↑ Elevated — higher than in the comparison group
CategoryNeurological
Also described asAxonal damage marker
Compared againstHC (healthy controls)
Associated symptomsNeurological LC, brain fog
Test typeBlood test (serum / plasma / whole blood)
LOINC code94635-5
SourceLai et al. 2023 — doi:10.3389/fmed.2023.1085988
Condition atlasLong COVID Biomarker Atlas

Other conditions where Neurofilament light chain (NfL) is reported

See the cross-condition hub: Neurofilament light chain (NfL) across conditions.

Trials, interventions and tests

Commercial test availability

Neurofilament light chain (NfL) — specialty laboratory test. Growing specialty/neurology send-out; check local lab menus.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Neurological markers in Long COVID

Full list: Long COVID Biomarker Atlas.

Frequently asked questions

Is Neurofilament light chain (NfL) high or low in Long COVID?

Elevated. Studies summarised in the OSMF atlas report higher Neurofilament light chain (NfL) in Long COVID than in healthy controls. Source: Lai et al. 2023.

What symptoms is Neurofilament light chain (NfL) associated with in Long COVID?

The cited literature associates this marker with Neurological LC, brain fog. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Neurofilament light chain (NfL)?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 94635-5. Commercial laboratories such as Quest Diagnostics, LabCorp list an orderable assay.

Is one abnormal Neurofilament light chain (NfL) result diagnostic of Long COVID?

No. No single biomarker is diagnostic of Long COVID. Neurofilament light chain (NfL) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Neurofilament light chain (NfL) specific to Long COVID?

No. The same marker is also reported in Alzheimer's Disease and Other Dementias, ME/CFS, Multiple Sclerosis, PACVS in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Neurofilament light chain (NfL) in Long COVID: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/long-covid/neurofilament-light-chain-nfl.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.